Company Valuation: Organo Corporation

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029
Market Cap 1 1,16,036 1,65,430 3,53,770 2,92,805 6,25,823 5,69,951 - -
Change - 42.57% 113.85% -17.23% 113.73% -8.93% - -
Enterprise Value (EV) 1 1,11,466 1,82,891 3,72,593 2,98,611 6,29,170 5,67,949 5,48,208 5,15,122
Change - 64.08% 103.72% -19.86% 110.7% -9.73% -3.48% -6.04%
P/E 12.6x 14.1x 20.4x 12.1x 22x 18.8x 16x 14.7x
PBR 1.53x 1.92x 3.47x 2.42x 4.38x 3.47x 3.1x 2.71x
PEG - 0.5x 0.4x 0.3x 1.3x 2.82x 0.9x 1.69x
Capitalization / Revenue 1.04x 1.25x 2.35x 1.79x 3.52x 2.8x 2.48x 2.32x
EV / Revenue 0.99x 1.38x 2.48x 1.83x 3.54x 2.79x 2.39x 2.1x
EV / EBITDA - 10.7x 15.2x 9.04x 15.9x 13.1x 10.6x 9.25x
EV / EBIT 10.3x 12x 16.5x 9.6x 16.7x 13.7x 11.5x 9.91x
EV / FCF 15.1x -9.14x 161x 16.3x 65.7x 21x 19.1x 16.2x
FCF Yield 6.64% -10.9% 0.62% 6.13% 1.52% 4.76% 5.24% 6.17%
Dividend per Share 2 40 62 102 160 200 226.7 246.7 260
Rate of return 1.58% 1.72% 1.32% 2.51% 1.47% 1.83% 1.99% 2.1%
EPS 2 200.7 255.8 376.9 525.4 617.7 658.9 774.2 841.6
Distribution rate 19.9% 24.2% 27.1% 30.5% 32.4% 34.4% 31.9% 30.9%
Net sales 1 1,12,069 1,32,426 1,50,356 1,63,269 1,77,654 2,03,900 2,29,600 2,45,433
EBITDA 1 - 17,036 24,554 33,045 39,629 43,200 51,650 55,700
EBIT 1 10,850 15,212 22,544 31,120 37,648 41,400 47,800 51,967
Net income 1 9,210 11,730 17,310 24,150 28,401 30,867 35,600 38,700
Net Debt 1 -4,570 17,461 18,823 5,806 3,347 -2,003 -21,743 -54,829
Reference price 2 2,532.50 3,605.00 7,700.00 6,370.00 13,610.00 12,395.00 12,395.00 12,395.00
Nbr of stocks (in thousands) 45,819 45,889 45,944 45,966 45,983 45,982 - -
Announcement Date 12/05/22 12/05/23 13/05/24 13/05/25 13/05/26 - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
18.81x2.79x13.15x1.83% 363.09Cr
22.18x2.87x15.33x1.39% 1TCr
207.4x3.26x20.47x - 406.94Cr
28.71x - - - 134.41Cr
32.56x2.18x18.55x0.54% 78Cr
Average 61.93x 2.77x 16.87x 1.25% 396.82Cr
Weighted average by Cap. 60.40x 2.91x 16.16x 1.46%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 6368 Stock
  4. Valuation Organo Corporation
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!